Report Detail
Global Cervical Cancer Market Insights, Forecast to 2025
- RnM3447703 |
- 22 May, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Other
Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract.
North America accounted for the largest share of the global market, followed by Europe.
Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region.
The global Cervical Cancer market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cervical Cancer market based on company, product type, end user and key regions.
This report studies the global market size of Cervical Cancer in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cervical Cancer in these regions.
This research report categorizes the global Cervical Cancer market by top players/brands, region, type and end user. This report also studies the global Cervical Cancer market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Advaxis Immunotherapies
Bionor Pharma
Dendreon Corporation
Inovio Pharmaceuticals
ISA Pharmaceuticals
Otsuka Pharmaceuticals
Profectus Biosciences
Virometix
Hologic
Market size by Product
Pap Testing
HPV Testing
Colposcopy
Cervical Biopsies
Market size by End User
Hospitals
Cancer Palliative care clinics
Diagnostic centers
Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cervical Cancer market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cervical Cancer market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cervical Cancer companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cervical Cancer submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cervical Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cervical Cancer market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cervical Cancer Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cervical Cancer Market Size Growth Rate by Product
- 1.4.2 Pap Testing
- 1.4.3 HPV Testing
- 1.4.4 Colposcopy
- 1.4.5 Cervical Biopsies
- 1.5 Market by End User
- 1.5.1 Global Cervical Cancer Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Cancer Palliative care clinics
- 1.5.4 Diagnostic centers
- 1.5.5 Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cervical Cancer Market Size
- 2.1.1 Global Cervical Cancer Revenue 2014-2025
- 2.1.2 Global Cervical Cancer Sales 2014-2025
- 2.2 Cervical Cancer Growth Rate by Regions
- 2.2.1 Global Cervical Cancer Sales by Regions
- 2.2.2 Global Cervical Cancer Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cervical Cancer Sales by Manufacturers
- 3.1.1 Cervical Cancer Sales by Manufacturers
- 3.1.2 Cervical Cancer Sales Market Share by Manufacturers
- 3.1.3 Global Cervical Cancer Market Concentration Ratio (CR5 and HHI)
- 3.2 Cervical Cancer Revenue by Manufacturers
- 3.2.1 Cervical Cancer Revenue by Manufacturers (2014-2019)
- 3.2.2 Cervical Cancer Revenue Share by Manufacturers (2014-2019)
- 3.3 Cervical Cancer Price by Manufacturers
- 3.4 Cervical Cancer Manufacturing Base Distribution, Product Types
- 3.4.1 Cervical Cancer Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cervical Cancer Product Type
- 3.4.3 Date of International Manufacturers Enter into Cervical Cancer Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cervical Cancer Sales by Product
- 4.2 Global Cervical Cancer Revenue by Product
- 4.3 Cervical Cancer Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cervical Cancer Breakdown Data by End User
6 North America
- 6.1 North America Cervical Cancer by Countries
- 6.1.1 North America Cervical Cancer Sales by Countries
- 6.1.2 North America Cervical Cancer Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cervical Cancer by Product
- 6.3 North America Cervical Cancer by End User
7 Europe
- 7.1 Europe Cervical Cancer by Countries
- 7.1.1 Europe Cervical Cancer Sales by Countries
- 7.1.2 Europe Cervical Cancer Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cervical Cancer by Product
- 7.3 Europe Cervical Cancer by End User
8 Asia Pacific
- 8.1 Asia Pacific Cervical Cancer by Countries
- 8.1.1 Asia Pacific Cervical Cancer Sales by Countries
- 8.1.2 Asia Pacific Cervical Cancer Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cervical Cancer by Product
- 8.3 Asia Pacific Cervical Cancer by End User
9 Central & South America
- 9.1 Central & South America Cervical Cancer by Countries
- 9.1.1 Central & South America Cervical Cancer Sales by Countries
- 9.1.2 Central & South America Cervical Cancer Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cervical Cancer by Product
- 9.3 Central & South America Cervical Cancer by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cervical Cancer by Countries
- 10.1.1 Middle East and Africa Cervical Cancer Sales by Countries
- 10.1.2 Middle East and Africa Cervical Cancer Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cervical Cancer by Product
- 10.3 Middle East and Africa Cervical Cancer by End User
11 Company Profiles
- 11.1 F. Hoffmann-La Roche
- 11.1.1 F. Hoffmann-La Roche Company Details
- 11.1.2 Company Business Overview
- 11.1.3 F. Hoffmann-La Roche Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 F. Hoffmann-La Roche Cervical Cancer Products Offered
- 11.1.5 F. Hoffmann-La Roche Recent Development
- 11.2 GlaxoSmithKline
- 11.2.1 GlaxoSmithKline Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GlaxoSmithKline Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GlaxoSmithKline Cervical Cancer Products Offered
- 11.2.5 GlaxoSmithKline Recent Development
- 11.3 Merck
- 11.3.1 Merck Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merck Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merck Cervical Cancer Products Offered
- 11.3.5 Merck Recent Development
- 11.4 Advaxis Immunotherapies
- 11.4.1 Advaxis Immunotherapies Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Advaxis Immunotherapies Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Advaxis Immunotherapies Cervical Cancer Products Offered
- 11.4.5 Advaxis Immunotherapies Recent Development
- 11.5 Bionor Pharma
- 11.5.1 Bionor Pharma Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bionor Pharma Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bionor Pharma Cervical Cancer Products Offered
- 11.5.5 Bionor Pharma Recent Development
- 11.6 Dendreon Corporation
- 11.6.1 Dendreon Corporation Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Dendreon Corporation Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Dendreon Corporation Cervical Cancer Products Offered
- 11.6.5 Dendreon Corporation Recent Development
- 11.7 Inovio Pharmaceuticals
- 11.7.1 Inovio Pharmaceuticals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Inovio Pharmaceuticals Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Inovio Pharmaceuticals Cervical Cancer Products Offered
- 11.7.5 Inovio Pharmaceuticals Recent Development
- 11.8 ISA Pharmaceuticals
- 11.8.1 ISA Pharmaceuticals Company Details
- 11.8.2 Company Business Overview
- 11.8.3 ISA Pharmaceuticals Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 ISA Pharmaceuticals Cervical Cancer Products Offered
- 11.8.5 ISA Pharmaceuticals Recent Development
- 11.9 Otsuka Pharmaceuticals
- 11.9.1 Otsuka Pharmaceuticals Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Otsuka Pharmaceuticals Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Otsuka Pharmaceuticals Cervical Cancer Products Offered
- 11.9.5 Otsuka Pharmaceuticals Recent Development
- 11.10 Profectus Biosciences
- 11.10.1 Profectus Biosciences Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Profectus Biosciences Cervical Cancer Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Profectus Biosciences Cervical Cancer Products Offered
- 11.10.5 Profectus Biosciences Recent Development
- 11.11 Virometix
- 11.12 Hologic
12 Future Forecast
- 12.1 Cervical Cancer Market Forecast by Regions
- 12.1.1 Global Cervical Cancer Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cervical Cancer Revenue Forecast by Regions 2019-2025
- 12.2 Cervical Cancer Market Forecast by Product
- 12.2.1 Global Cervical Cancer Sales Forecast by Product 2019-2025
- 12.2.2 Global Cervical Cancer Revenue Forecast by Product 2019-2025
- 12.3 Cervical Cancer Market Forecast by End User
- 12.4 North America Cervical Cancer Forecast
- 12.5 Europe Cervical Cancer Forecast
- 12.6 Asia Pacific Cervical Cancer Forecast
- 12.7 Central & South America Cervical Cancer Forecast
- 12.8 Middle East and Africa Cervical Cancer Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cervical Cancer Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cervical Cancer . Industry analysis & Market Report on Cervical Cancer is a syndicated market report, published as Global Cervical Cancer Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cervical Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
